Best Health Care Grants in American Samoa

The DoW Military Burn, Patient-Centered Research Award aims to enhance the implementation of burn care research into clinical practice for military settings. The FY26 program supports clinical trials and research that directly benefit burn patients in resource-limited environments, fostering collaborations between experienced researchers and junior scholars. This initiative addresses critical gaps in combat burn care, ensuring effective interventions and guidelines are developed and utilized in operational battlespaces.

The FY26 Military Burn Research Program (MBRP) Discovery Award aims to support groundbreaking research in combat-relevant burn care. This award encourages innovative and exploratory studies that provide new insights and foundational data for future clinical research. The focus is on novel approaches that lay the groundwork for scientific advancements and product development in burn care, ensuring robust preliminary data generation for subsequent research initiatives.

The FY26 Military Burn Research Program (MBRP) Technology/Therapeutic Development Award (TTDA) aims to translate promising preclinical findings into burn products for clinical use in challenging environments. This award supports the development of both tangible products, like medical devices, and knowledge products that enhance health outcomes. A new Mentorship Option encourages collaboration between experienced researchers and junior scientists, fostering the next generation of leaders in military burn care research.

The FY26 Melanoma Research Program Team Science Award promotes collaborative, hypothesis-driven research to enhance melanoma care. This funding supports multidisciplinary teams of two to three Principal Investigators (PIs) to tackle complex challenges in melanoma. With approximately $18.9M available, the program aims to fund nine projects with a maximum of $2.1M per award over three years. Awards will be made by September 30, 2027, using FY26 funds that expire on September 30, 2032.

The FY26 Melanoma Research Program Idea Award encourages innovative and high-risk research to advance melanoma treatment. With a budget of approximately $5.6M for 10 awards, each grant can fund up to $0.56M over a maximum of 2 years. The program aims to support projects that establish proof of principle and generate preliminary data for future funding opportunities. Notably, preliminary data is discouraged, and applicants must receive an invitation to submit a full application after the pre-application stage.

The FY26 Melanoma Research Program Survivorship Research Award aims to enhance the well-being of melanoma survivors through innovative research. This funding opportunity supports studies that prioritize quality of life, involving melanoma survivors or their families as collaborators. With approximately $2.04M available, two awards of up to $1.02M each will be granted for research over a maximum period of three years. Applications must be submitted by September 30, 2027, to be funded with FY26 resources.

The Melanoma Research Program Melanoma Academy Scholar Award supports early career investigators within seven years of their initial faculty appointment. This unique virtual academy fosters collaboration among established researchers and Scholars, focusing on research and career potential in melanoma. With approximately $1.54M allocated to fund two Scholar Awards, each capped at $0.77M, the maximum performance period is three years, and funding is expected to be available until September 30, 2032.

The FY26 Melanoma Research Program Focused Program Award for Rare Melanomas supports multidisciplinary research initiatives aimed at addressing critical questions in rare melanomas. This award requires collaboration between an Initiating Principal Investigator and up to two Partnering PIs, with the inclusion of a rare melanoma survivor or patient advocate in the project team. Approximately $5.6M is allocated to fund two awards, each capped at $2.8M, over a maximum performance period of four years.

The Lung Cancer Translational Research Award (TRA) for FY26 supports innovative translational research aimed at transforming promising lung cancer ideas into clinical applications. This award emphasizes advanced preclinical studies and pilot clinical trials of novel interventions, addressing critical research areas within the Lung Cancer Research Program. Applicants can choose between two funding levels to advance their impactful studies, thereby contributing to significant advancements in lung cancer treatment.

The Lung Cancer Patient-Centered Outcomes and Survivorship Award (PCOSA) aims to enhance health outcomes for lung cancer patients by promoting patient-centered research. This FY26 initiative encourages projects that address key areas of survivorship and requires the involvement of lung cancer survivors or caregivers in research teams. Additionally, it supports both translational and clinical research, including pilot clinical trials, to improve the overall patient experience.

The FY26 Lung Cancer Research Program's Idea Development Award supports innovative, high-risk research aimed at significant breakthroughs in lung cancer treatment. It encourages new concepts in their early stages, requiring preliminary data to demonstrate feasibility, although not necessarily from lung cancer studies. This program also features a New Investigator category, allowing early-career researchers to compete separately for funding, fostering a diverse range of impactful investigations.

The DoW Lupus Impact Award, funded by the US Army Medical Command, aims to support innovative research that can significantly advance the understanding and treatment of lupus. This award focuses on high-risk, high-reward projects that align with the FY26 Lupus Research Program priorities. Notably, it does not permit clinical trials and limits applicants to one submission per mechanism, encouraging fresh and impactful ideas in lupus research.

The DoW Lupus Transformative Vision Development Award supports planning and pilot studies aimed at generating preliminary data for future interventional lupus research. It encourages collaboration with lupus consumer advocates and allows for phase 0/1 clinical trials. However, phase 2/3 trials and animal studies are not permitted. Successful studies may lead to further funding through the Lupus Research Program. This initiative is critical for advancing lupus research and improving patient outcomes.

The NIH Collaborative International Research Project aims to foster international research collaborations that align with the NIH mission. This grant encourages applications that incorporate at least one international subproject, offering oversight and tracking for NIH-funded international initiatives. Projects should leverage unique resources or populations abroad, contributing to advancements in health sciences relevant to NIH's objectives. This initiative underscores the importance of global partnerships in enhancing research capabilities and outcomes in the United States.

The AASM Foundation Disaster Relief Fund, established in 2005, provides essential financial aid to AASM accredited sleep centers impacted by natural disasters. By supporting these centers, the fund ensures that medical care remains accessible to patients during crises. Past funding has assisted centers after events like Hurricane Katrina and the 2010 Haiti earthquake, helping them recover and restore operations quickly. This initiative highlights the commitment to maintaining patient care in the face of adversity.

The Computational Mathematics program supports research that integrates computation with mathematical analysis, encouraging innovative algorithm development and application. Proposals may range from individual projects to interdisciplinary teams, focusing on new computational techniques to address significant application challenges. The program also emphasizes training for junior mathematicians through hands-on research. Conference proposals must adhere to strict submission timelines to ensure review and funding opportunities, fostering collaboration within the mathematical sciences.

The Family Unification Program (FUP) aims to assist families and youth at risk of homelessness by providing Housing Choice Voucher (HCV) assistance. It targets families facing housing issues that could lead to out-of-home placement for children and youth aged 18-24 who have aged out of foster care. The program offers flexible voucher durations, with extensions available under specific conditions, ensuring support for those in need of stable housing.

The National Institute of Environmental Health Sciences (NIEHS) invites applications for the Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional). This program supports interdisciplinary research centers focused on biomedical and environmental science. Eligible institutions must be accredited higher education establishments. Applications are due by 5:00 PM local time, and successful submissions will undergo a rigorous peer-review process to ensure quality and relevance in addressing hazardous substance issues.

This funding opportunity aims to advance HIV/AIDS research by implementing human new approach methodologies (NAMs) to reduce the reliance on specific pathogen free (SPF) animal models. It emphasizes the integration of NAMs-enabled frameworks for in vitro testing while supporting essential SPF colony resources. The initiative seeks to enhance research rigor and reproducibility through innovative strategies that prioritize human-relevant models, ultimately improving HIV research outcomes and facilitating collaborative development in the field.

The BRAIN Initiative seeks innovative proposals for preclinical proof of concept studies on novel recording and modulation technologies aimed at diagnosing and treating central nervous system (CNS) disorders. This initiative supports diverse, multidisciplinary teams to enhance our understanding of the human CNS and prepare technologies for first-in-human studies. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 60 days prior to the proposal deadline.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to support the career development of promising audiologists through rigorous postdoctoral research in biomedical, behavioral, or clinical sciences. This initiative encourages independent investigation in health-related research relevant to NIDCD's mission. Applications are due on various dates, with the next deadline on June 13, 2024, providing opportunities for advancing research in audiology and related fields.

The NIDCD Mentored Career Development Award supports postdoctoral Au.D./Ph.D. audiologists in their research and career development. This grant aims to foster independence in scientific health-related research relevant to the NIDCD's mission. Key deadlines for applications span from June 2024 to May 2027, providing numerous opportunities for eligible candidates to secure funding and advance their careers in the biomedical and clinical sciences.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to foster the development of promising audiologists through comprehensive postdoctoral research experiences. This funding opportunity supports individuals in biomedical, behavioral, or clinical sciences, helping them become independent researchers. The deadlines for applications span from June 2024 to May 2027, ensuring ample time for preparation and submission.

The BRAIN Initiative invites applications for clinical studies aimed at advancing devices for recording and modulation in the human central nervous system. This funding opportunity focuses on small clinical trials that provide vital data for device development, particularly for treatments of central nervous system disorders. Investigators are encouraged to explore both non-significant and significant risk studies to enhance understanding of device functionality and design, ultimately contributing to improved clinical outcomes.

The BRAIN Initiative aims to foster innovation in the development of next-generation devices for recording and modulating the human central nervous system. This funding opportunity encourages clinical studies and translational research to create advanced therapeutic and diagnostic devices for neurological disorders. Applicants are advised to submit Letters of Intent 60 days before the proposal deadline. This initiative emphasizes milestones and collaboration with NIH staff throughout the project.

The FY26 Peer Reviewed Medical Research Program's Platform Clinical Translation Award facilitates early-phase clinical trials for innovative healthcare technologies, catering to the needs of military Service Members, Veterans, and their Families. The program allows collaborations among multiple Principal Investigators and mandates an external advisory board with patient advocate involvement. Approximately $30M is allocated to fund two applications, each capped at $15M, over a maximum period of four years, with funding contingent on performance milestones.